Zivo BioscienceZIVO
13F holders, Q1 2026 (March 31)2holders −1
0new positions
1sold out
$6.75avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding Zivo Bioscience Inc. (ZIVO) in their 13F filings, down 1 from Q4 2025. 0 opened new positions and 1 sold out. The largest holders were CoreCap Advisors, LLC ($29K) and Huntington National Bank ($702).
- Company
- Zivo Bioscience Inc.
- CUSIP
- 98978N309
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $4K |
All 13F filers, Q4 2025 → Q1 2026: 500 shares sold, net −500 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| CoreCap Advisors, LLC | 0.00% | No change | 4,360 | $29K |
| Huntington National Bank | 0.00% | No change | 104 | $702 |
"% of holder's portfolio" is ZIVO's weight in each manager's 13F, not the share of Zivo Bioscience Inc. the manager owns.